iShares Biotechnology ETF $IBB Stake Reduced by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 15.7% in the second quarter, Holdings Channel.com reports. The fund owned 22,528 shares of the financial services provider’s stock after selling 4,186 shares during the period. Oppenheimer & Co. Inc.’s holdings in iShares Biotechnology ETF were worth $4,285,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Basepoint Wealth LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $29,000. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the second quarter valued at approximately $25,000. Caitlin John LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Finally, Cornerstone Planning Group LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $35,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $198.26 on Friday. iShares Biotechnology ETF has a 1-year low of $136.89 and a 1-year high of $201.72. The company has a 50 day moving average price of $186.87 and a 200 day moving average price of $176.26.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a dividend of $0.0238 per share. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.